Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02336217 · ClinicalTrials.gov registry record · NA

Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations

A NA study of Diabetes Mellitus, sponsored by Marshall University.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02336217 is a NA study of Diabetes Mellitus that is active but no longer recruiting, run by Marshall University. The registered enrollment target is 40 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02336217, a NA study of Diabetes Mellitus, is active but no longer recruiting, sponsored by Marshall University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to determine the utility of an algorithm for better glucose control in diabetic patients communicated via an App to help improve outcomes and reduce urgent care and ER visits as well as improve A1C and quality of life.

Conditions Studied

Interventions

  • OTHER Experimental Group instructions for glucose management via App
  • OTHER Placebo Comparator general instructions

Study Locations (1)

West Virginia

  • Marshall Health - Huntington

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2014-09
Est. Completion 2026-06
Phase NA

Sponsor

Marshall University

12 total trials

What the Registry Record Tells You About NCT02336217

The ClinicalTrials.gov registry entry for NCT02336217 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The listed sponsor is Marshall University, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Experimental Group instructions for glucose management via App is the first listed.

NCT02336217 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT02336217 about?

NCT02336217 is a clinical study titled "Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations". The purpose of this pilot study is to determine the utility of an algorithm for better glucose control in diabetic patients communicated via an App to help improve outcomes and reduce urgent care and ER visits as well as improve A1C and quality of life.

What is the current status of trial NCT02336217?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2014-09. Estimated completion is 2026-06.

What conditions does trial NCT02336217 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT02336217?

The interventions under investigation include: Experimental Group instructions for glucose management via App (OTHER), Placebo Comparator general instructions (OTHER).

Who is sponsoring clinical trial NCT02336217?

This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02336217 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.